Celldex Therapeutics buy Citigroup Inc.
Start price
20.08.25
/
50%
€18.40
Target price
20.08.26
€41.27
Performance (%)
21.74%
Price
16.01.26
€22.00
Summary
This prediction is currently active. The prediction currently has a performance of 21.74%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | -6.780% | -6.780% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by Citigroup_Inc_ for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Citigroup Inc. from $56.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€28.20
07.10.24
07.10.24
€63.74
07.10.25
07.10.25
-20.57%
08.10.25
08.10.25
